C2 Pharma Menu
  • Products
      • c2p_navi_products_APIsProducts Image
      • Products
      • APIs
      • R&D PIPELINE
  • Services
  • Company
      • c2pharma_navi_aboutCompany Image
      • Company
      • ABOUT US
      • NETWORK
      • CAREERS
  • News
  • Contact

Author: c2pred

FINANCIAL TIMES GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY CONFERENCE

Posted on 22. November 201823. February 2021 by c2pred
Posted in General

C2 PHARMA and ANKLAM EXTRAKT® announce R&D collaboration

Posted on 5. October 201820. March 2019 by c2pred
Posted in Press Release

Validation

Posted on 4. October 20184. October 2018 by c2pred
Posted in Press Release

C2 PHARMA leads

Posted on 4. October 201823. February 2021 by c2pred
Posted in Press Release

C2 PHARMA brings reliable cannabidiol (cbd) api source to pharma companies and expands its r&d product pipeline

Posted on 2. October 20182. October 2018 by c2pred
Posted in General

CPhI 2017: C2 PHARMA acquires R&D synthesis services company and establishes cold-chain logistics spin-off

Posted on 16. October 201723. February 2021 by c2pred
Posted in General

Centroflora CMS changes its name to C2 PHARMA

Posted on 4. October 201723. February 2021 by c2pred
Posted in General

CEP approval

Posted on 2. October 201723. February 2021 by c2pred
Posted in General

CPhI Award nomination

Posted on 20. September 201726. September 2018 by c2pred
Posted in General

Information Brief

Posted on 5. September 201725. September 2018 by c2pred
Posted in General

Finalist

Posted on 19. September 201612. January 2021 by c2pred
Posted in General

INFORMATION BRIEF

Posted on 9. September 201625. September 2018 by c2pred
Posted in General

Winner

Posted on 27. October 201512. January 2021 by c2pred
Posted in General

Major expansion

Posted on 4. October 201526. September 2018 by c2pred
Posted in General

Finalist

Posted on 21. September 201512. January 2021 by c2pred
Posted in General

Brazilian Pavillion

Posted on 1. September 201525. September 2018 by c2pred
Posted in General

Award

Posted on 22. May 201512. January 2021 by c2pred
Posted in General

CHEMICAL & ENGINEERING NEWS

Posted on 16. March 201512. January 2021 by c2pred
Posted in General

Paris

Posted on 1. September 201425. September 2018 by c2pred
Posted in General

Recent Posts

  • C2 PHARMA Completes Multiple Regulatory Filings, Expands Portfolio
  • Andrew Badrot, C2 PHARMA CEO, speaks on working to mitigate risks for future crises like the COVID-19 pandemic
  • Interview with Andrew Badrot, C2 PHARMA CEO, a “Lëtzebuerger Merkur” Featured Story
  • C2 PHARMA Finalist in Excellence in Pharma: Sustainability, the CPhI Pharma Awards 2020
  • The Impact of Covid-19 on the Pharmaceutical Industry

Archives

  • February 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019
  • July 2019
  • June 2019
  • March 2019
  • November 2018
  • October 2018
  • June 2018
  • October 2017
  • September 2017
  • September 2016
  • October 2015
  • September 2015
  • May 2015
  • March 2015
  • September 2014

Categories

  • General
  • Press Release

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • APIs

    • Atropine base
    • Atropine Sulfate
    • Homatropine Methylbromide
    • Homatropine Hydrobromide
    • Digoxin
    • Digoxin Micron
    • Pilocarpine Hydrochloride
    • Pilocarpine Nitrate
    • Scopolamine Butylbromide
  • R&D Pipeline
  • Services
  • About Us
  • Network
  • Careers
  • News
  • CONTACT

info@c2pharma.com

C2Pharma Logo
  • General Terms of Sales
  • Data Privacy